Profile data is unavailable for this security.
About the company
Zota Health Care Limited is an India-based drug development, manufacturing and marketing company. The Company manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over the counter (OTC) products. The Company’s business model comprises three verticals, namely Domestic, Exports and Retail Pharmacy Chain (Davaindia). Its Marketing business vertical involves the direct distribution of generic drugs, OTC products, and other pharmaceutical products through the Company’s distribution network across India. It has a portfolio of more than 3,000 products in various categories, such as generics, OTC products, allopathic, ayurvedic and others. In the Retail Pharmacy Chain business vertical, it operates a chain of pharmacy stores under the brand Davaindia. Its domestic products include AMLOTOZ AT Tab, APIXACEED 2.5 Tab, APIXACEED 5 Tab, ATRONA 10 Tab, ATRONA 20 Tab, ATRONA 40 Tab, ATRONA ASP 75 Cap, ATRONA ASP 150 Cap, ATRONA ASP 20/75 Cap, ATRONA FB Tab and others.
- Revenue in INR (TTM)1.80bn
- Net income in INR-143.48m
- Incorporated2000
- Employees338.00
- LocationZota Health Care LtdZota House 2/896Hira Modi Street SagrampuraSURAT 395002IndiaIND
- Phone+91 2 612331601
- Websitehttps://www.zotahealthcare.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bajaj Healthcare Ltd | 4.73bn | -143.27m | 7.91bn | 1.06k | -- | 2.84 | 59.49 | 1.67 | -5.18 | -30.36 | 171.62 | 100.86 | 0.5681 | 1.44 | 2.32 | -- | -1.72 | 6.97 | -3.51 | 12.73 | 46.18 | 30.16 | -3.03 | 7.20 | 0.8096 | 1.64 | 0.5446 | 5.38 | -29.69 | 5.04 | -133.30 | -- | 15.08 | -- |
| Jagsonpal Pharmaceuticals Ltd | 2.09bn | 224.63m | 8.63bn | 940.00 | 38.52 | 4.60 | 35.76 | 4.13 | 8.47 | 8.47 | 78.31 | 70.88 | 1.01 | 5.27 | 13.12 | -- | 10.90 | 10.95 | 12.30 | 13.29 | 55.00 | 58.17 | 10.76 | 9.21 | 9.63 | 26.29 | 0.0455 | 43.81 | -11.83 | 4.58 | -15.94 | 25.50 | -35.69 | 82.06 |
| Vimta Labs Ltd | 3.18bn | 410.09m | 10.54bn | 1.37k | 26.07 | 3.30 | 14.02 | 3.31 | 18.24 | 18.24 | 141.64 | 144.20 | 0.8349 | 3.23 | 3.81 | -- | 10.76 | 10.53 | 12.60 | 12.77 | 76.02 | 73.65 | 12.89 | 12.16 | 2.46 | 24.79 | 0.0566 | 11.15 | 0.0223 | 8.40 | -14.87 | 10.13 | 35.88 | 0.00 |
| Remus Pharmaceuticals Ltd | 450.27m | 85.03m | 10.65bn | 38.00 | 113.08 | 40.98 | 118.56 | 23.65 | 63.92 | 63.92 | 361.02 | 176.36 | -- | -- | -- | 11,849,290.00 | -- | -- | -- | -- | 52.39 | -- | 18.88 | -- | 1.35 | -- | 0.2933 | -- | 82.17 | -- | 151.14 | -- | -- | -- |
| Bliss GVS Pharma Ltd | 7.70bn | 754.54m | 10.69bn | 763.00 | 14.42 | 1.11 | 9.91 | 1.39 | 7.08 | 7.08 | 72.86 | 92.39 | 0.6498 | 3.45 | 1.95 | -- | 6.88 | 6.46 | 8.37 | 8.22 | 50.39 | 44.21 | 10.59 | 9.92 | 4.34 | 17.97 | 0.0905 | 7.93 | 2.48 | -3.03 | 6.49 | -9.42 | -8.33 | -12.94 |
| Syncom Formulations (India) Ltd | 2.63bn | 253.14m | 10.86bn | 799.00 | 33.97 | 3.77 | 36.15 | 4.12 | 0.34 | 0.34 | 3.56 | 3.07 | 0.6732 | 7.42 | 2.95 | -- | 6.47 | 7.50 | 9.00 | 10.23 | 40.44 | 34.59 | 9.61 | 9.38 | 2.38 | 5.57 | 0.201 | -- | 17.45 | 7.12 | 26.13 | 17.95 | -- | -- |
| Kopran Ltd | 6.15bn | 509.56m | 11.28bn | 394.00 | 22.29 | 2.30 | 17.67 | 1.84 | 10.50 | 10.50 | 126.95 | 101.90 | 0.8824 | 2.99 | 3.28 | -- | 7.32 | 8.47 | 10.22 | 12.23 | 34.60 | 34.18 | 8.29 | 8.89 | 1.44 | 43.23 | 0.168 | 25.41 | 11.54 | 11.42 | 87.11 | 16.23 | 12.53 | -- |
| Lincoln Pharmaceuticals Ltd | 5.81bn | 933.05m | 11.34bn | 1.70k | 12.15 | 1.91 | 10.91 | 1.95 | 46.58 | 46.58 | 289.81 | 295.98 | 0.9017 | 3.78 | 3.90 | -- | 14.49 | 13.95 | 16.61 | 16.54 | 52.06 | 51.21 | 16.07 | 14.71 | 4.01 | 60.95 | 0.0018 | -- | 13.76 | 9.66 | 27.99 | 13.88 | 21.54 | 3.71 |
| Beta Drugs Ltd | 2.56bn | 347.57m | 11.44bn | 315.00 | 32.92 | 8.06 | 24.99 | 4.47 | 36.15 | 36.15 | 266.28 | 147.68 | 1.24 | 4.44 | 3.72 | 8,126,721.00 | 16.85 | -- | 25.36 | -- | 41.88 | -- | 13.58 | -- | 1.43 | 18.21 | 0.098 | -- | 23.54 | -- | 23.73 | -- | -- | -- |
| Zota Health Care Ltd | 1.80bn | -143.48m | 12.19bn | 338.00 | -- | 13.20 | 212.25 | 6.75 | -5.59 | -5.59 | 70.40 | 34.81 | 0.9341 | 2.02 | 6.55 | -- | -7.42 | -1.38 | -10.54 | -1.85 | 46.43 | 36.48 | -7.95 | -1.33 | 0.7851 | -2.62 | 0.5143 | -- | 28.96 | 16.08 | -148.54 | -- | 39.85 | 0.00 |
| Windlas Biotech Ltd | 6.31bn | 581.87m | 13.25bn | 1.05k | 22.80 | 2.94 | 18.50 | 2.10 | 27.94 | 27.94 | 302.99 | 216.33 | 1.09 | 5.79 | 4.99 | -- | 10.07 | -- | 13.50 | -- | 37.21 | -- | 9.22 | -- | 2.15 | 58.58 | 0.008 | -- | 22.97 | -- | 36.51 | -- | -- | -- |
| Ngl Fine Chem Ltd | 3.39bn | 413.43m | 14.00bn | 343.00 | 33.87 | 5.33 | 26.44 | 4.13 | 66.92 | 66.92 | 548.61 | 425.11 | 1.05 | 4.51 | 4.36 | -- | 12.87 | 15.06 | 16.61 | 19.58 | 53.18 | 46.79 | 12.20 | 13.15 | 1.96 | 30.64 | 0.1218 | 3.06 | 21.79 | 17.20 | 101.58 | 15.47 | 14.49 | 0.00 |
| Hester Biosciences Ltd | 3.05bn | 188.89m | 14.64bn | 693.00 | 69.15 | 5.02 | 38.19 | 4.81 | 24.89 | 24.89 | 392.38 | 343.01 | 0.4572 | 1.20 | 3.85 | -- | 3.18 | 6.15 | 4.00 | 7.69 | 68.52 | 68.83 | 6.95 | 12.83 | 1.31 | 1.84 | 0.4466 | 23.27 | 14.45 | 11.33 | -29.06 | -14.59 | 1.49 | -11.42 |
| SMS Pharmaceuticals Ltd | 7.09bn | 498.26m | 16.05bn | 1.10k | 32.20 | 2.99 | 19.89 | 2.26 | 5.89 | 5.89 | 83.84 | 63.36 | 0.7413 | 2.18 | 3.69 | -- | 5.14 | 5.43 | 7.41 | 7.33 | 29.83 | 32.67 | 6.94 | 7.87 | 0.905 | 3.63 | 0.3436 | 6.59 | 35.86 | 8.81 | 805.82 | 4.47 | 8.41 | 9.86 |
